View Alert


Originator: MHRA Drug Alerts

From: Himal Makwana

Issue date: 03-Aug-2020 10:59:32

This alert has been issued to:
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director

  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Foundation Trusts (England) - Chief Executive
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive
  • GP - Locum
  • NHS 111 and Out of hours providers
  • Dispensing GP Practices
  • DHSC Supply Disruption - Medicines
  • Primary Care Networks

Action category: Class 3: Action within 5 days

Title: CLASS 3 DRUG ALERT, ACTION WITHIN 5 DAYS, ACCORD-UK LIMITED, DIGOXIN TABLETS BP 250 MICROGRAM, PL 0142/0083

Broadcast content:

Accord-UK Ltd has informed us of an issue related to decommissioning of a specific batch. Upon decommissioning at the pharmacy, there have been reports stating that when scanning the serialised 2D code, the status of the packs may report as 'EXPORT.' Although there is no risk to product quality, any remaining stock should be quarantined and returned. 

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.



Additional information: NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacy.
GP Practices: Please note this alert is for Dispensing GP Practices only.


Alert reference: EL (20)A/35

Attachments:
Cascade to:
  • #COMMUNITYPHARMACISTS#
  • #DISPENSING GP#
  • #HospitalPharmacy#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency